Literature DB >> 20592938

Synthesis and characterization of oxorhenium(V)-'3+1' mixed thiolate [SNS]/[S] and [ONS]/[S] complexes. Crystal and molecular structures of [ReO(eta-SCH(2)C(5)H(3)NCH(2)S)(eta-C(6)H(4)Br-4-S)], [ReO(eta-SCH(2)C(5)H(3)NCH(2)O)(eta-C(6)H(4)X-4-S)] (X=Cl, OMe), [ReO(eta-SCH(2)C(5)H(3)NCH(2)O)(eta-C(6)H(4)OCH(3)-4-CH(2)S)] and [ReO(eta-SCH(2)C(5)H(3)NCH(2)S)(eta-C(5)H(4)NH-2-S)][Cl].

Xiaoyuan Chen1, Frank J Femia, John W Babich, Jon Zubieta.   

Abstract

The reaction of [ReOCl(3)(PPh(3))(2)] with the tridentate ligands 2,6-dithiomethylpyridine (4) or 6-thiomethyl-2-pyridinemethanol (5) and the appropriate monothiols, such as para-substituted benzenethiols (C(6)H(4)X-4-SH) (where X=F, Cl, Br and OCH(3)) and para-substituted benzylmercaptans (C(6)H(4)X-4-CH(2)SH) (where X=F, Cl and OCH(3)) in the presence of Et(3)N leads to the isolation of a series of integrated '3+1' oxorhenium(V) complexes. Similarly, reaction of [ReOCl(3)(PPh(3))(2)] with 2-mercaptopyridine and 4 afforded a cationic oxorhenium(V) complex, [ReO(eta(3)-SCH(2)C(5)H(3)NCH(2)S)(eta(1)-C(5)H(4)NH-2-S)][Cl] (22). Crystal data for 10, C(13)H(11)BrNOS(3)Re: triclinic, P1, a=7.2909(5), b=14.1978(9), c=15.991(1) A, alpha=77.184(1), beta=86.588(1), gamma=75.507(1) degrees , V=1562.69(18) A(3), Z=4. For 16, C(13)H(11)ClNO(2)S(2)Re: orthorhombic, P2(1)2(1)2(1), a=6.9728(6), b=13.477(1), c=15.761(1) A, V=1481.1(2) A(3), Z=4. For 18, C(14)H(14)NO(3)S(2)Re: monoclinic, P2(1)/c, a=15.6512(14), b=7.6678(7), c=13.732(1) A, beta=112.489(1) degrees , V=1522.7(2) A(3), Z=4. For 21, C(15)H(16)NO(3)S(2)Re: monoclinic, P2(1)/c, a=13.929(1), b=7.741(1), c=15.583(2) A, beta=103.600(2) degrees , V=1633.1(3) A(3), Z=4. For 22, C(12)H(11)ClN(2)OS(3)Re: monoclinic, C2(1)/(c), a=27.827(3), b=8.529(1), c=14.957(2) A, beta=119.314(2) degrees , V=3095.3(6) A(3), Z=8.

Entities:  

Year:  2000        PMID: 20592938      PMCID: PMC2893354          DOI: 10.1016/s0020-1693(00)00209-7

Source DB:  PubMed          Journal:  Inorganica Chim Acta        ISSN: 0020-1693            Impact factor:   2.545


  15 in total

1.  Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.

Authors:  E Prats; F Aisa; M D Abós; L Villavieja; F García-López; M J Asenjo; P Razola; J Banzo
Journal:  J Nucl Med       Date:  1999-02       Impact factor: 10.057

2.  99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals.

Authors:  S Liu; D S Edwards
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

3.  Oxorhenium(V) complexes containing tridentate Schiff-base and monothiol coligands.

Authors:  Frank J Femia; Xiaoyuan Chen; John W Babich; Jon Zubieta
Journal:  Inorganica Chim Acta       Date:  2000-04-20       Impact factor: 2.545

4.  Novel 99mTc aminobisthiolato/monothiolato "3 + 1" mixed ligand complexes: structure-activity relationships and preliminary in vivo validation as brain blood flow imaging agents.

Authors:  I C Pirmettis; M S Papadopoulos; E Chiotellis
Journal:  J Med Chem       Date:  1997-08-01       Impact factor: 7.446

5.  Syn-Anti Isomerism in a Mixed-Ligand Oxorhenium Complex, ReO[SN(R)S][S].

Authors:  M. S. Papadopoulos; I. C. Pirmettis; M. Pelecanou; C. P. Raptopoulou; A. Terzis; C. I. Stassinopoulou; E. Chiotellis
Journal:  Inorg Chem       Date:  1996-12-04       Impact factor: 5.165

6.  Integrated "3+1" oxorhenium(V) complexes as estrogen mimics.

Authors:  M B Skaddan; J A Katzenellenbogen
Journal:  Bioconjug Chem       Date:  1999 Jan-Feb       Impact factor: 4.774

7.  Glutathione-mediated metabolism of technetium-99m SNS/S mixed ligand complexes: a proposed mechanism of brain retention.

Authors:  B A Nock; T Maina; D Yannoukakos; I C Pirmettis; M S Papadopoulos; E Chiotellis
Journal:  J Med Chem       Date:  1999-03-25       Impact factor: 7.446

8.  Progestin-rhenium complexes: metal-labeled steroids with high receptor binding affinity, potential receptor-directed agents for diagnostic imaging or therapy.

Authors:  J P DiZio; R Fiaschi; A Davison; A G Jones; J A Katzenellenbogen
Journal:  Bioconjug Chem       Date:  1991 Sep-Oct       Impact factor: 4.774

Review 9.  Therapeutic radionuclides: production and decay property considerations.

Authors:  W A Volkert; W F Goeckeler; G J Ehrhardt; A R Ketring
Journal:  J Nucl Med       Date:  1991-01       Impact factor: 10.057

10.  Stability versus reactivity of "3+1" mixed-ligand technetium-99m complexes in vitro and in vivo.

Authors:  R Syhre; S Seifert; H Spies; A Gupta; B Johannsen
Journal:  Eur J Nucl Med       Date:  1998-07
View more
  2 in total

1.  Exploring oxorhenium '3+1' mixed-ligand complexes carrying the S-benzyl-3-[(2-hydroxyphenyl)methylene]dithiocarbazate [ONS]/monothiol [S] donor set: synthesis and characterization.

Authors:  Xiaoyuan Chen; Frank J Femia; John W Babich; Jon Zubieta
Journal:  Inorganica Chim Acta       Date:  2000-09-11       Impact factor: 2.545

2.  N-Centered Tripodal Phosphine Re(V) and Tc(V) Oxo Complexes: Revisiting a [3 + 2] Mixed-Ligand Approach.

Authors:  Saul M Cooper; Andrew J P White; Thomas R Eykyn; Michelle T Ma; Philip W Miller; Nicholas J Long
Journal:  Inorg Chem       Date:  2022-05-11       Impact factor: 5.436

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.